HomeVTYX • NASDAQ
Ventyx Biosciences Inc
Follow
$0.94
6.02%
After Hours:(1.03%)-0.0097
$0.93
Closed: Apr 4, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.42M | -35.61% |
Net income | -29.35M | 37.22% |
Net profit margin | — | — |
Earnings per share | -0.41 | 48.10% |
EBITDA | -32.35M | 35.66% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.32M | -13.84% |
Total assets | 276.56M | -0.41% |
Total liabilities | 22.52M | -33.32% |
Total equity | 254.05M | — |
Shares outstanding | 71.13M | — |
Price to book | 0.28 | — |
Return on assets | -28.06% | — |
Return on capital | -29.22% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -29.35M | 37.22% |
Cash from operations | -23.25M | 54.99% |
Cash from investing | -11.00M | -123.84% |
Cash from financing | -25.00K | -104.27% |
Net change in cash | -34.51M | -585.85% |
Free cash flow | -12.07M | 64.95% |
Previous close
$1.00
Day range
$0.90 - $1.00
Year range
$0.90 - $5.66
Market cap
66.85M USD
Avg Volume
812.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Website
Employees
81
